[Use of natulan in the different histological variants of lymphogranulomatosis].
The results of natulan therapy in III patients with spread lymphogranulomatosis are reported. An analysis of the dependence of the remission frequency and duration on different morphological variants of lymphogranulomatosis has shown that the incidence of remissions was high and practically identical in patients with nodular sclerosis, the lymphocytic and mixed cell type. The effect of natulan was found to be limited in the variant "Lymphocytic depletion".
D000293:Adolescent; D000328:Adult; D002986:Clinical Trials as Topic; D004341:Drug Evaluation; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D011344:Procarbazine / Q000008:administration & dosage / Q000627:therapeutic use*; D012075:Remission, Spontaneous; D013997:Time Factors
D011344:Procarbazine
Primenenie natulana pri razlichnykh gistologicheskikh variantakh limfogranulematoza.